tiprankstipranks
Advertisement

ILOW - ETF AI Analysis

Compare

Top Page

ILOW

AB International Low Volatility Equity ETF (ILOW)

Rating:61Neutral
Price Target:
ILOW, the AB International Low Volatility Equity ETF, has a solid overall rating driven by high-quality holdings like Novartis and Roche, which benefit from strong financial performance, healthy pipelines, and supportive earnings call sentiment. ASML and OCBC also add strength through robust growth and valuation support, though some holdings such as Schneider Electric and BAE Systems face bearish technical trends and relatively expensive valuations, which slightly weigh on the fund’s rating. The main risk factor is that several key positions show signs of being expensive or overbought, which could limit future upside.
Positive Factors
Strong Top Holdings Performance
Several of the largest positions, including ASML, Prysmian, and major financial names, have shown strong gains this year, supporting the ETF’s overall returns.
Broad International Diversification
The fund spreads its investments across many countries such as the UK, Japan, France, the U.S., and others, which helps reduce the impact of problems in any single market.
Balanced Sector Mix
Holdings are spread across financials, industrials, consumer sectors, health care, and more, limiting the risk of being too exposed to one industry.
Negative Factors
Moderate Expense Ratio
The ETF’s fee is not extremely high but is above what some low-cost index funds charge, which slightly reduces the net return to investors over time.
Concentration in a Few Key Markets
A large portion of assets is focused in the UK and Japan, meaning performance is more sensitive to economic or political issues in those countries.
Limited Technology Exposure
The fund has relatively small exposure to the technology sector, which could cause it to lag if tech stocks continue to drive global market gains.

ILOW vs. SPDR S&P 500 ETF (SPY)

ILOW Summary

ILOW is the AB International Low Volatility Equity ETF, built to invest in stocks from many countries while trying to smooth out the ups and downs. It doesn’t track a specific index, but follows a theme of owning international companies that have shown more stable price movements. The fund holds well-known names like ASML Holding and Novartis, and spreads money across sectors such as financials, industrials, and consumer companies. Someone might invest for global diversification with a focus on steadier growth. A key risk is that it still owns stocks, so its value can go up and down with the overall market.
How much will it cost me?The AB International Low Volatility Equity ETF (ILOW) has an expense ratio of 0.5%, meaning you’ll pay $5 per year for every $1,000 invested. This is higher than average for ETFs because it uses an actively managed strategy to select stocks with lower volatility, which requires more research and management compared to passively managed funds. It’s designed for investors seeking stability in international markets.
What would affect this ETF?The AB International Low Volatility Equity ETF (ILOW) could benefit from global economic stability and growth, particularly in sectors like financials, technology, and healthcare, which make up a significant portion of its holdings. However, it may face challenges from rising interest rates, geopolitical tensions, or regulatory changes in the international markets where it operates, potentially impacting its broad-based exposure and top holdings like SAP SE and Shell. Its focus on low-volatility stocks may help mitigate risks during market downturns but could limit returns in high-growth periods.

ILOW Top 10 Holdings

ILOW’s story is about steady global growth with a low-drama tilt. ASML has been a big long-term engine but is recently losing a bit of steam, while Novartis and Roche keep the health-care side humming along with relatively steady gains. Financials like OCBC and Mitsubishi UFJ are rising and quietly pulling more weight, giving the fund a solid banking backbone across Asia. Industrial names such as Schneider Electric and Prysmian are more mixed, occasionally wobbling but still supporting this broadly diversified, non-U.S. portfolio.
Name
Company Name
Weight %
Market Value
Market Cap
Yearly Gain
Overall Rating
ASML Holding NV2.91%$53.15M€530.35B118.10%
76
Outperform
Novartis AG2.01%$36.72MCHF238.06B36.54%
80
Outperform
OCBC1.96%$35.76MS$130.02B57.35%
71
Outperform
Schneider Electric1.94%$35.43M€147.95B9.67%
62
Neutral
BAE Systems1.91%$34.84M£59.34B14.07%
61
Neutral
Roche Holding AG1.85%$33.84M$359.89B37.39%
73
Outperform
1.81%$33.03M
1.78%$32.51M
Mitsubishi UFJ Financial Group1.74%$31.82M¥40.94T41.42%
76
Outperform
Tesco plc1.68%$30.75M£30.62B18.46%
74
Outperform

ILOW Technical Analysis

Technical Analysis Sentiment
Positive
Last Price
Price Trends
50DMA
45.32
Positive
100DMA
44.57
Positive
200DMA
43.68
Positive
Market Momentum
MACD
RSI
STOCH
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For ILOW, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 45.76, equal to the 50-day MA of 45.32, and equal to the 200-day MA of 43.68, indicating a bullish trend. The MACD of ― indicates undefined momentum. The RSI at ― is undefined, neither overbought nor oversold. The STOCH value of ― is undefined, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for ILOW.

ILOW Peer Comparison

Comparison Results
Name
Price
Price Target
AUM
Expense Ratio
Overall Rating
$1.82B0.50%
61
Neutral
$2.21B0.54%
60
Neutral
$1.71B0.85%
60
Neutral
$1.34B0.65%
69
Neutral
$1.15B0.59%
65
Neutral
$1.15B0.45%
64
Neutral
Performance Comparison
Ticker
Company Name
Price
Change
% Change
ILOW
AB International Low Volatility Equity ETF
46.89
6.78
16.90%
CGIC
Capital Group International Core Equity ETF
WCMI
First Trust WCM International Equity ETF
IDVO
Amplify International Enhanced Dividend Income ETF
MFSI
MFS Active International ETF
APIE
ActivePassive International Equity ETF
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents
Advertisement